LRRK2 and Parkinson disease: Indeed, G2019S, the most common and highly penetrant mutation in LRRK2 and also the most common monofactorial cause of PD identified until now, increases the autophosphorylation of LRRK2 in a gain-of-function pathogenic mechanism [41].